The Primary Sclerosing Cholangitis Market is estimated to be valued at US$ 3,604.7 Mn in 2022 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023-2030.
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |